Catalyst Wire Dossier Catalyst Wire Dossier

KamRAB

· Kamada, Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KamRAB, covering 2021-09-05 to 2021-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Post-marketing Study of KamRAB Administered as a Single Dose With Active Rabies Vaccine in Children Exposed to Rabies [Phase 3]

See pricing